BOROWIEC, A. M.; WŁASZCZUK, A.; OLAKOWSKA, E.; LEWIN-KOWALIK, J. TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients. Medicine and Pharmacy Reports, [S. l.], v. 95, n. 3, p. 243–250, 2022. DOI: 10.15386/mpr-2187. Disponível em: https://medpharmareports.com/index.php/mpr/article/view/2187. Acesso em: 1 jul. 2025.